Impact of Colchicine Therapy on Arrhythmia Recurrence After Acute Pericardial Effusion
Impact of Colchicine Therapy on Arrhythmia Recurrence After Acute Pericardial Effusion Following Catheter Ablation of Atrial Fibrillation
Sponsor: Yong Seog Oh
This PHASE4 trial investigates Pericardial Effusion and is currently completed. Yong Seog Oh leads this study, which shows 10 recorded versions since 2014 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
May 2024 — Jul 2024 [monthly]
Completed PHASE4
Status: Unknown Status → Completed
-
Oct 2021 — May 2024 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
▶ Show 5 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Recruiting PHASE4
-
May 2019 — Jan 2021 [monthly]
Recruiting PHASE4
-
Jul 2018 — May 2019 [monthly]
Recruiting PHASE4
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE4
First recorded
Jul 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Yong Seog Oh
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Seoul, South Korea